Ectopic expression of human apolipoprotein D in Arabidopsis plants lacking chloroplastic lipocalin partially rescues sensitivity to drought and oxidative stress.


Journal

Plant physiology and biochemistry : PPB
ISSN: 1873-2690
Titre abrégé: Plant Physiol Biochem
Pays: France
ID NLM: 9882449

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 30 06 2020
accepted: 09 11 2020
pubmed: 3 12 2020
medline: 7 2 2021
entrez: 2 12 2020
Statut: ppublish

Résumé

The chloroplastic lipocalin (LCNP) is induced in response to various abiotic stresses including high light, dehydration and low temperature. It contributes to protection against oxidative damage promoted by adverse conditions by preventing accumulation of fatty acid hydroperoxides and lipid peroxidation. In contrast to animal lipocalins, LCNP is poorly characterized and the molecular mechanism by which it exerts protective effects during oxidative stress is largely unknown. LCNP is considered the ortholog of human apolipoprotein D (APOD), a protein whose lipid antioxidant function has been characterized. Here, we investigated whether APOD could functionally replace LCNP in Arabidopsis thaliana. We introduced APOD cDNA fused to a chloroplast transit peptide encoding sequence in an Arabidopsis LCNP KO mutant line and challenged the transgenic plants with different abiotic stresses. We demonstrated that expression of human APOD in Arabidopsis can partially compensate for the lack of the plastid lipocalin. The results are consistent with a conserved function of APOD and LCNP under stressful conditions. However, if the results obtained with the drought and oxidative stresses point to the protective effect of constitutive expression of APOD in plants lacking LCNP, this effect is not as effective as that conferred by LCNP overexpression. Moreover, when investigating APOD function in thylakoids after high light stress at low temperature, it appeared that APOD could not contribute to qH, a slowly reversible form of non-photochemical chlorophyll fluorescence quenching, as described for LCNP. This work provides a base of understanding the molecular mechanism underlying LCNP protective function.

Identifiants

pubmed: 33262014
pii: S0981-9428(20)30560-X
doi: 10.1016/j.plaphy.2020.11.009
pii:
doi:

Substances chimiques

APOD protein, human 0
Apolipoproteins D 0
Lipocalins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

265-274

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Patricia Henri (P)

Aix-Marseille Université, CEA, CNRS, UMR 7265, Institut Biosciences et Biotechnologies d'Aix-Marseille, Plant Protein Protection Laboratory, CEA/Cadarache, F-13108, Saint-Paul-lez-Durance, France.

Dominique Rumeau (D)

Aix-Marseille Université, CEA, CNRS, UMR 7265, Institut Biosciences et Biotechnologies d'Aix-Marseille, Plant Protein Protection Laboratory, CEA/Cadarache, F-13108, Saint-Paul-lez-Durance, France. Electronic address: dominique.rumeau@cea.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH